Tandem Nucleophilic Addition/Cyclization
Reaction in the Synthesis of Ketimine-Type
Iminosugars
Jean-Bernard Behr,* Adel Kalla, Dominique Harakat, and
Richard Plantier-Royon
Institut de Chimie Moléculaire de Reims (ICMR), UFR
Sciences, CNRS, BP 1039, 51687 Reims Cedex 2, France
jb.behr@uniV-reims.fr
ReceiVed December 7, 2007
FIGURE 1. Structures of unsaturated iminosugars.
ketimine moiety have been isolated from the branches of
Broussonetia kazinoki.6 Broussonetines U and U1 (Figure 1)
might belong to the sixth class of iminosugars, i.e., the
polyhydroxypyrrolines.7 Broussonetines are 18-carbon chain
alkaloids featuring a 13-carbon substituent at the 2-alkyl position
of the 5-membered ring. Because broussonetines appear to be
biosynthesized through intermediates related to sphingosines,
which play important roles in biological processes, the synthesis
and biological evaluation of these alkaloids and related ana-
logues is of great interest.8 There has been enormous effort
expended in the search for synthetic methods toward the
standard iminosugars. Nevertheless, the development of a
general approach to polyhydroxyketimines remains challenging.
A first example of such an approach has been described
recently,9 which involved an exo-imino- to endo-iminocyclitol
rearrangement as the key step, occurring in 25–42% yield.
However, the introduction of the C-2 substituent appeared at
an early stage of the synthetic sequence, limiting the versatility
required for the synthesis of a library of analogues. Herein, we
describe a new synthesis of novel cyclic ketimines sugars 1a-h
The biological activity of unsaturated iminosugars has not
yet been extensively studied because of a lack of general
synthetic methods. A practical synthesis of these cyclic
ketimine sugars was developed, which was based on a
tandem addition-cyclization reaction of a Grignard reagent
to a ω-methanesulfonylglycononitrile.
Iminosugars are naturally occurring sugar mimics displaying
well-documented glycosidase1 or glycosyltransferase2 inhibition
potencies. Recent years have seen an increasing interest in
natural or synthetic iminosugars as biological tools or potential
therapeutics in the treatment of various infections,3 cancer,4 and
certain genetic disorders.5 Iminosugars are usually classified into
five structural classes: the polyhydroxylated pyrrolidines, pyr-
rolizidines, piperidines, indolizidines, and nortropanes. Recently,
two polyhydroxylated alkaloids featuring an unprecedented
(1) Iminosugars as glycosidase inhibitors: Nojirimycin and beyond; Stütz,
A. E., Ed.; Wiley-VCH: Weinheim, Germany, 1999.
(6) (a) Tsukamoto, D.; Shibano, M.; Okamoto, R.; Kusano, G. Chem. Pharm.
Bull. 2001, 49, 492. (b) Tsukamoto, D.; Shibano, M.; Kusano, G. Chem. Pharm.
Bull. 2001, 49, 1487.
(2) (a) Gautier-Lefebvre, I.; Behr, J.-B.; Guillerm, G.; Muzard, M. Eur.
J. Med. Chem. 2005, 40, 1255. (b) Djebaili, M.; Behr, J.-B. J. Enzyme Inhib.
Med. Chem. 2005, 20, 123. (c) Compain, P.; Martin, O. R. Curr. Top. Med.
Chem. 2003, 3, 525. (d) Compain, P.; Martin, O. R. Bioorg. Med. Chem. 2001,
9, 3077.
(7) Nectrisine, the cyclic imine nominally derived from dehydration of
4-amino-4-deoxy-D-arabinose, is an example of naturally occurring aldimine-
type 5-membered iminosugar and might be classified into the pyrroline-derived
iminosugars as well. In opposition to ketimines, numerous syntheses of nectrisine
and other cyclic sugar aldimines have appeared in the literature, which use, for
instance, a chlorination/elimination strategy from the corresponding pyrrolidine.
For an example, see: Chapman, T. M.; Courtney, S.; Hay, P.; Davis, B. G. Chem.
Eur. J. 2003, 9, 3397.
(3) (a) Bosco, M.; Bisseret, P.; Constant, P.; Eustache, J. Tetrahedron Lett.
2007, 48, 153. (b) Steet, R.; Chung, S.; Lee, W.-S.; Pine, C. W.; Do, H.; Kornfeld,
S. Biochem. Pharmacol. 2007, 73, 1376. (c) Liautard, V.; Christina, A. E.;
Desvergnes, V.; Martin, O. R. J. Org. Chem. 2006, 71, 7337. (d) Behr, J.-B.;
Gainvors-Claisse, A.; Belarbi, A. Nat. Prod. Res. 2006, 20, 1308. (e) Robina,
I.; Moreno-Vargas, A. J.; Carmona, A. T.; Vogel, P. Curr. Drug Metab. 2004,
5, 329. (f) Behr, J.-B. Curr. Med. Chem. (Anti InfectiVe Agents) 2003, 2, 173.
(4) (a) Moreno-Vargas, A. J.; Carmona, A. T.; Mora, F.; Vogel, P.; Robina,
I. Chem. Commun. 2005, 4949. (b) Fiaux, H.; Popowycz, F.; Favre, S.; Schütz,
C.; Vogel, P.; Gerber-Lemaire, S.; Juillerat-Jeanneret, L. J. Med. Chem. 2005,
48, 4237. (c) Nishimura, Y. Curr. Top. Med. Chem. 2003, 3, 575. (d) Barchi,
J. J. Curr. Pharm. Des. 2000, 6, 485.
(8) Shibano, M.; Tsukamoto, D.; Kusano, G. Heterocycles 2002, 57, 1539.
(9) Only one example of a general synthesis of ketimine-type iminosugars
has been reported so far; see: Moriarty, R. M.; Mitan, C. I.; Branza-Nichita, N.;
Phares, K. R.; Parrish, D. Org. Lett. 2006, 8, 3465. Some other unsaturated
iminosugars have been obtained by specific transformations; see: (a) Izquierdo,
I.; Plaza, M. T.; Rodríguez, M.; Franco, F.; Martos, A. Tetrahedron 2005, 61,
11697. (b) Davis, B. G.; Maughan, M. A.; Chapman, T. M.; Villard, R.; Courtney,
S. Org. Lett. 2002, 4, 103. (c) Yokoyama, M.; Ikenogami, T.; Togo, H. J. Chem.
Soc., Perkin Trans. l 2000, 2067. (d) Schuster, M.; Blechert, S. Tetrahedron:
Asymmetry 1999, 10, 3139. (e) Bouix, C.; Bisseret, P.; Eustache, J. Tetrahedron
Lett. 1998, 39, 825. (f) Takayama, S.; Martin, R.; Wu, J.; Laslo, K.; Siuzdak,
G.; Wong, C.-H. J. Am. Chem. Soc. 1997, 119, 8146.
(5) (a) Yu, Z.; Sawkar, A. R.; Whalen, L. J.; Wong, C.-H.; Kelly, J. W.
J. Med. Chem. 2007, 50, 94. (b) Wennekes, T.; van den Berg, R. J.; Donker,
W.; van der Marel, G. A.; Strijland, A.; Aerts, J. M.; Overkleeft, H. S. J. Org.
Chem. 2007, 72, 1088. (c) Faugeroux, V.; Génisson, Y.; Andrieu-Abadie, N.;
Colie´, S.; Levade, T.; Baltas, M. Org. Biomol. Chem. 2006, 4, 4437.
3612 J. Org. Chem. 2008, 73, 3612–3615
10.1021/jo702616x CCC: $40.75 2008 American Chemical Society
Published on Web 03/22/2008